Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
The development of exosome-based delivery platforms is particularly attractive, as exosomes exhibit excellent biocompatibility, low immunogenicity, and the ability to cross biological barriers, making them ideal nanocarriers for gene therapy in osteosarcoma (6567)
Blood 80(10):2604-9, 1992
Cancer Res 70(6):2424-2434, 2010
Enhances the bodys ability to eliminate harmful compounds and restore liver function
Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antiproliferative activity
US$ 26.47
US$ 21.07
US$ 21.74
US$ 24.99
US$ 29.25
US$ 23.37
US$ 27.76
US$ 22.56
